Ginkgo Bioworks Stock

ginkgobioworks.comHealthcareFounded: 2008Funding to Date: $785.53MM

Ginkgo Bioworks is the developer of a cell programming platform enabling the growth of biotechnology across diverse markets, from food to fragrance to pharmaceuticals.

Register for Details

For more details on financing and valuation for Ginkgo Bioworks, register or login.

Please provide your first name.
Please provide your last name.
Please provide a valid email address.

By registering, you agree to the Forge Terms of Use. Already registered? Click here to log in

Enterprise Value (based on primary financings)

Enterprise Value

View Enterprise Value for Ginkgo Bioworks.

Register Today

Team

Management Team

Barry Canton
Co-Founder
Peter Boynton
Chief Commercial Officer
Austin Che
Co-Founder
Ena Cratsenburg
Chief Business Officer
Jason Kelly
Co-Founder, Chief Executive Officer & Board Member
Reshma Shetty
Co-Founder, President & Board Member
Tom Knight
Co-Founder

Board Members

Marjin Dekkers
Christian Henry

Other companies like Ginkgo Bioworks in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$3.6B
Sector
Last Round Est. Valuation
$334.19MM
Sector
Last Round Est. Valuation
$150MM
Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$296.3MM
Sector
Last Round Est. Valuation
$4.8B

News

FGen, a spinout of ETH Zurich, is a contract research organization specializing in strain development and optimization.
Project Beacon COVID-19 was started by F-Prime Capital, GV, and the Broad Institute to help implement COVID-19 testing in Massachusetts and its environs.
NEW YORK, Jan. 18, 2022 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Ginkgo...